Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 13;15(22):5396.
doi: 10.3390/cancers15225396.

Ultrasound Patterns of Hepatocellular Carcinoma and Their Prognostic Impact: A Retrospective Study

Affiliations

Ultrasound Patterns of Hepatocellular Carcinoma and Their Prognostic Impact: A Retrospective Study

Chiara Barteselli et al. Cancers (Basel). .

Abstract

Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. Abdominal ultrasound (US) is by far the most widely used first-level exam for the diagnosis of HCC. We aimed to assess whether different ultrasound patterns were related to tumor prognosis.

Methods: We retrospectively reviewed all patients with a new diagnosis of HCC (single nodule) and undergoing radiofrequency thermal ablation (RFTA) at our clinic between January 2009 and December 2021. Patients were classified according to four HCC ultrasound patterns: 1A, single capsulated nodule; 1B, well capsulated intra-node nodule; 1C, cluster consisting of capsulated nodules; and 2, non-capsulated nodule.

Results: 149 patients were analysed; median follow-up time was 43 months. US patterns 1A (32.9%) and 1B (61.1%) were the most commonly seen. Median overall survival (OS) and recurrence-free survival (RFS) from RFTA were 54 months (95% CI, 42-66) and 22 months (95% CI, 12-32), respectively. Pattern 1A showed the best OS. Compared to pattern 1A, 1B was independently associated with worse OS (51 months (95% CI, 34-68) vs. 46 months (95% CI, 18-62)) and RFS (34 months (95% CI, 27-41) vs. 18 months (95% CI, 12-24)). Patterns 1C and 2 were associated with worse RFS compared to 1A, while no difference was seen for OS. Among baseline clinical variables, pattern 1B exhibited higher histological grade (p = 0.048) and tumor dimension (p = 0.034) compared to pattern 1A.

Conclusions: Our findings demonstrate that different US patterns correlate with different survival outcomes and tumor behavior in patients with HCC. Prospective studies are needed to confirm these results.

Keywords: abdominal ultrasound; hepatocellular carcinoma; histological grade; overall survival; recurrence-free survival; ultrasound pattern.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Illustrative images of hepatocellular carcinoma nodules divided into the four ultrasound patterns, with the relevant macroscopic appearance showed below. (1A)—single, capsulated nodule; (1B)—intra-node node, well capsulated; (1C)—cluster formation consisting of capsulated nodules; and (2)—non-capsulated.
Figure 2
Figure 2
Kaplan-Mejer curve for overall survival. Time expressed in months.
Figure 3
Figure 3
Kaplan-Mejer curves for overall survival and recurrence-free survival stratified by ultrasound patterns. (a) Overall survival; (b) Recurrence-free survival.
Figure 4
Figure 4
Box plot graph showing the distribution of nodule sizes according to US pattern 1A or 1B.

Similar articles

Cited by

References

    1. Rumgay H., Ferlay J., de Martel C., Georges D., Ibrahim A.S., Zheng R., Wei W., Lemmens V.E.P.P., Soerjomataram I. Global, regional and national burden of primary liver cancer by subtype. Eur. J. Cancer. 2022;161:108–118. doi: 10.1016/j.ejca.2021.11.023. - DOI - PubMed
    1. Singal A.G., Kanwal F., Llovet J.M. Global trends in hepatocellular carcinoma epidemiology: Implications for screening, prevention and therapy. Nat. Rev. Clin. Oncol. 2023 doi: 10.1038/s41571-023-00825-3. - DOI - PubMed
    1. McGlynn K.A., Petrick J.L., El-Serag H.B. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021;73((Suppl. S1)):4–13. doi: 10.1002/hep.31288. - DOI - PMC - PubMed
    1. Vogel A., Meyer T., Sapisochin G., Salem R., Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400:1345–1362. doi: 10.1016/S0140-6736(22)01200-4. - DOI - PubMed
    1. Estes C., Razavi H., Loomba R., Younossi Z., Sanyal A.J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123–133. doi: 10.1002/hep.29466. - DOI - PMC - PubMed

LinkOut - more resources